Pneumologie, Allergologie Praxis Dr. Thomas Ginko

The medical center is at the forefront of allergy and immunology research, focusing on innovative treatments for birch pollen-induced allergic rhinitis and rhinoconjunctivitis. Through advanced clinical trials, the center explores the efficacy of novel therapies, such as mannan-conjugated birch pollen allergoids, administered subcutaneously to alleviate symptoms and reduce medication dependency during peak pollen seasons.

• Birch pollen-induced allergic rhinitis
• Birch pollen-induced allergic rhinoconjunctivitis

By conducting rigorous, double-blind, placebo-controlled studies, the center contributes significantly to the understanding and management of seasonal allergies, offering hope for improved quality of life for affected individuals.

Specializing in respiratory medicine, the center is dedicated to advancing treatment options for severe asthma. The REIMAGINE study evaluates the real-world effectiveness of Mepolizumab, aiming to achieve clinical remission in patients. This research is pivotal in understanding long-term outcomes and adherence to treatment protocols, ultimately enhancing patient care and management strategies.

• Severe asthma

Through comprehensive studies, the center is committed to improving therapeutic approaches and patient outcomes in respiratory diseases, setting new standards in clinical practice.